Literature DB >> 20001486

ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis.

Guillaume Gautier1, Annie Verschueren, Armelle Monnier, Shahram Attarian, Emmanuelle Salort-Campana, Jean Pouget.   

Abstract

Respiratory muscle involvement is one of the main prognostic factors in amyotrophic lateral sclerosis (ALS). Acute respiratory failure is sometimes the first manifestation of the disease, although onset can be more insidious. In the present retrospective study, it was proposed to review the clinical features and to assess the effects of non-invasive ventilation (NIV) on the prognosis of patients with respiratory onset, which was taken to be present when the first symptoms of muscular weakness were dyspnoea at exertion, dyspnoea at rest, or orthopnoea. Respiratory onset ALS is uncommon, since it accounts for less than 3% of ALS cases. ALS with respiratory onset has some common clinical features: male predominance, frequent camptocormia or dropped head, frequent widespread fasciculations, limb mobility fairly well preserved and significant weight loss in the early stages. ALS patients with respiratory onset still have a poor prognosis compared with those with bulbar or spinal forms. NIV should be proposed promptly because it improves the symptoms, general state of health and survival time. Efforts should be made to inform general practitioners and chest physicians and remind them that neuromuscular respiratory insufficiency may be attributable to this particular form of ALS.

Entities:  

Mesh:

Year:  2010        PMID: 20001486     DOI: 10.3109/17482960903426543

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  17 in total

Review 1.  Management of respiratory symptoms in ALS.

Authors:  Orla Hardiman
Journal:  J Neurol       Date:  2010-11-17       Impact factor: 4.849

2.  Tollgate-based progression pathways of ALS patients.

Authors:  Özden O Dalgıç; F Safa Erenay; Kalyan S Pasupathy; Osman Y Özaltın; Brian A Crum; Mustafa Y Sir
Journal:  J Neurol       Date:  2019-01-25       Impact factor: 4.849

Review 3.  Ventilatory control in ALS.

Authors:  Nicole L Nichols; J Van Dyke; L Nashold; I Satriotomo; M Suzuki; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-18       Impact factor: 1.931

Review 4.  Diagnosis of muscle diseases presenting with early respiratory failure.

Authors:  Gerald Pfeffer; Marcus Povitz; G John Gibson; Patrick F Chinnery
Journal:  J Neurol       Date:  2014-11-07       Impact factor: 4.849

5.  Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.

Authors:  Philippe Corcia; Paul H Gordon
Journal:  Ther Clin Risk Manag       Date:  2012-08-27       Impact factor: 2.423

Review 6.  Pathophysiological Concepts and Treatment of Camptocormia.

Authors:  N G Margraf; A Wrede; G Deuschl; W J Schulz-Schaeffer
Journal:  J Parkinsons Dis       Date:  2016-06-16       Impact factor: 5.568

7.  Age-Related Uptake of Heavy Metals in Human Spinal Interneurons.

Authors:  Roger Pamphlett; Stephen Kum Jew
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

Review 8.  Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Ramya Ranganathan; Shaila Haque; Kayesha Coley; Stephanie Shepheard; Johnathan Cooper-Knock; Janine Kirby
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

Review 9.  Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis.

Authors:  Svitlana Garbuzova-Davis; Robert Shell; Hilmi Mustafa; Surafuale Hailu; Alison E Willing; Paul R Sanberg; Cesario V Borlongan
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

10.  Titin mutation segregates with hereditary myopathy with early respiratory failure.

Authors:  Gerald Pfeffer; Hannah R Elliott; Helen Griffin; Rita Barresi; James Miller; Julie Marsh; Anni Evilä; Anna Vihola; Peter Hackman; Volker Straub; David J Dick; Rita Horvath; Mauro Santibanez-Koref; Bjarne Udd; Patrick F Chinnery
Journal:  Brain       Date:  2012-05-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.